Completed × Has results × Neoplasms, Plasma Cell × Clear all BRUOG-407
Phase NA Completed
18 enrolled 8 charts
Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Phase 1 Completed
14 enrolled 15 charts
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Phase 2 Completed
39 enrolled 15 charts
LOOMIS
Completed
67 enrolled 24 charts
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Completed
633 enrolled 15 charts
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor
Phase 2 Completed
28 enrolled 10 charts
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Phase 4 Completed
165 enrolled 9 charts
Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma
Phase NA Completed
16 enrolled 8 charts
Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma
Phase 2 Completed
99 enrolled 12 charts
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
Phase 1/2 Completed
12 enrolled 19 charts
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Completed
514 enrolled 16 charts
Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
Phase 3 Completed
52 enrolled 11 charts
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
Phase 2 Completed
79 enrolled 10 charts
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Completed
508 enrolled 16 charts
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Phase 1/2 Completed
95 enrolled 13 charts
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Phase 2 Completed
5 enrolled 10 charts
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
Phase 3 Completed
332 enrolled 11 charts
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
Phase 1/2 Completed
26 enrolled 13 charts
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
Phase 1/2 Completed
28 enrolled 10 charts
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Phase 3 Completed
1,718 enrolled 22 charts
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
Phase 2 Completed
117 enrolled 27 charts
OPTIMAL
Phase 2 Completed
31 enrolled 13 charts
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
Phase 2 Completed
88 enrolled 6 charts
BMT CTN 0102
Phase 3 Completed
710 enrolled 19 charts
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Phase 2 Completed
45 enrolled 8 charts
T-BiRD
Phase 2 Completed
26 enrolled 16 charts
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
Phase 3 Completed
637 enrolled 15 charts
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Phase 2 Completed
6 enrolled 16 charts
Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant
Phase 2 Completed
40 enrolled 8 charts
Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
Phase 1/2 Completed
60 enrolled 7 charts
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Phase NA Completed
39 enrolled 13 charts
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
Phase 1/2 Completed
30 enrolled 7 charts
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Phase 2 Completed
71 enrolled 10 charts
High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma
Phase 2 Completed
75 enrolled 11 charts
A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Phase 3 Completed
205 enrolled 11 charts
Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
Phase 2 Completed
28 enrolled 8 charts
PANORAMA-1
Phase 3 Completed
767 enrolled 17 charts
Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2 Completed
39 enrolled 13 charts
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Phase 2 Completed
20 enrolled 11 charts
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
Phase 3 Completed
74 enrolled 17 charts
Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 1/2 Completed
33 enrolled 14 charts
Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
Phase 2 Completed
124 enrolled 13 charts
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Phase 1/2 Completed
103 enrolled 12 charts
Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma
Phase 2 Completed
77 enrolled 15 charts
Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
Phase 1/2 Completed
50 enrolled 10 charts
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
Phase NA Completed
66 enrolled 9 charts
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer
Phase 2 Completed
142 enrolled 11 charts
Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma
Phase 2 Completed
55 enrolled 14 charts
CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
Phase 2 Completed
378 enrolled 13 charts